TrialJournal of endocrinological investigation

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

D Glintborg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.